AI algorithm landscape assessment
The challenge
Our client wanted to identify companies and institutions developing AI algorithms to detect a rare disease.
Our solution
We provided a competitive analysis of AI algorithms for a rare disease. Analysis was from the medical perspective to assess the level of evidence that exists to support each algorithm. We identified institutions and companies developing AI algorithms for the rare disease and mapped the AI algorithms to the patient diagnostic journey. Lastly, we developed a framework to evaluate the level of evidence supporting the AI algorithms.
The results
Overall, we offered strategies for the client to consider regarding its own AI algorithm and competitive AI algorithms for a rare disease.
Jump to a slide with the slide dots.
Patient Finding Through Data Tokenization
Refined HCP targeting in rare disease using integrated data, boosting hit rates from 10% to 50% and delivering 3x ROI in 6 months.
Read moreDigital share of voice and sentiment analysis at key congress
Used GenAI to benchmark digital voice in oncology, boosting engagement & leadership via LinkedIn, DEI & clinical messaging.
Read moreData Strategy Development
Future-proofed data strategy with Putnam: gaps identified, vendors vetted, leading to a first US multi-source tokenized DB.
Read more